IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Takeda Pharmaceutical Co LTD

Q4 2024 Holdings

Filed 2025-02-12 | 12 holdings | $26.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
HilleVax, Inc.COM43157M102$13.9M6,724,00052.4%
Ovid Therapeutics Inc.(OVID)COM690469101$7.0M7,531,99626.4%
Xilio Therapeutics, Inc.(XLO)COM98422T100$1.4M1,475,1215.3%
Equillium, Inc.(EQ)COM29446K106$1.4M1,824,9775.2%
Shattuck Labs, Inc.(STTK)COM82024L103$623.9K515,6192.3%
American Well Corp(AMWL)COM03044L204$563.6K77,7332.1%
Lyell Immunopharma, Inc.COM55083R104$526.9K823,3172.0%
Turnstone Biologics Corp.COM90042W100$447.9K895,8241.7%
Third Harmonic Bio, Inc.(THRD)COM88427A107$379.0K36,8351.4%
Rani Therapeutics Holdings, Inc.(RANI)COM753018100$278.4K203,1901.0%
Standard Biotools Inc.(LAB)COM34385P108$28.9K16,5150.1%